Research source
AI algorithm was authorized by FDA for use in detecting pulmonary hypertension from ECG.
Based on ECG-AI Pulmonary Hypertension (PH) 12-Lead algorithm (1020) - FDA AI-enabled device listing
Published by FDA AI-Enabled Medical DevicesMar 28, 2026
Government sourceMedium evidenceStage unknown
What researchers observed
FDA authorized the ECG-AI Pulmonary Hypertension 12-Lead algorithm on 2026-03-28 for cardiovascular use.
What this could mean
FDA authorization shows this AI tool meets regulatory standards, pointing toward reliable use in research or clinical workflows.
What researchers still need to learn
Researchers still need to learn whether this AI improves patient outcomes or clinical decisions in practice.